Intravesical Electromotive Mitomycin C Versus Passive Transport Mitomycin C for High Risk Superficial Bladder Cancer: A Prospective Randomized Study-Reference-Cited by-同舟云学术

Intravesical Electromotive Mitomycin C Versus Passive Transport Mitomycin C for High Risk Superficial Bladder Cancer: A Prospective Randomized Study

Published:2003-09 Issue:3 Volume:170 Page:777-782
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

DI STASI SAVINO M.¹,GIANNANTONI ANTONELLA¹,STEPHEN ROBERT L.¹,CAPELLI GIOVANNI¹,NAVARRA PIERLUIGI¹,MASSOUD RENATO¹,VESPASIANI GIUSEPPE¹

Affiliation:

1. From the Departments of Urology and Clinical Biochemistry, Tor Vergata University and Institute of Pharmacology, Catholic University, Rome, Department of Urology, University of Perugia, Perugia, Physion Laboratories, Medolla and Department of Science and Society, University of Cassino, Cassino, Italy

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor?;Jakse;J Urol,1987

2. Follow-up of patients with “superficial” transitional cell carcinoma of the bladder: the case for a change in policy;Abel;Br J Urol,1993

3. Natural history of early bladder cancer;Bostwick;J Cell Biochem,1992

4. The treated natural history of high risk superficial bladder cancer: 15-year outcome;Cookson;J Urol,1997

5. The limits of bacillus Calmette-Guérin for carcinoma in situ of the bladder;Kim;J Urol,2001

Cited by 208 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental and New Approaches for Bladder Preservation in Intermediate and High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC);Research and Reports in Urology;2024-04

2. Progress and challenges in intravesical drug delivery;Expert Opinion on Drug Delivery;2024-01-02

3. Homologous Targeting and Adhesion Abilities of Cellular Microvesicles for Enhanced Intravesical Therapy of Bladder Cancer;Advanced Therapeutics;2023-12-15

4. Local Drug Delivery in Bladder Cancer: Advances of Nano/Micro/Macro-Scale Drug Delivery Systems;Pharmaceutics;2023-12-03

5. Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023;Journal of Urologic Oncology;2023-11-30